The protocol received prospective institutional review board approval from Zagazig University Faculty of Medicine (IRB #633/1-Sep-2024) and was registered retrospectively on ClinicalTrials.gov in September 2025 (NCT07155304)
I have been battling Lyme Disease for years, however, here in Canada, this disease does not exist nor do they offer any treatments other than antibiotics, thus I have been suffering for years and going from doctors to doctors at no avail in fact getting worse and worse
Patients need comprehensive support and follow-up, and thats exactly what these new guidelines emphasize
While drowsiness is not a recognized side effect of semaglutide (Ozempic, Wegovy, Rybelsus), fatigue is listed as a common adverse reaction in FDA labeling, particularly for Wegovy
Pahwa M, Pahwa P, Kathuria S
22 news release